%PDF-1.3
%
3 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
6 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2019-11-11T11:43:49-08:00
2017-09-15T14:54:11+05:30
application/pdf
NEU-2017-29013-introduction-ver9-Leggieri_3P 1..3
uuid:97dac6ee-edda-4dd2-a43f-476e102964c1
uuid:9c8b8bd3-5c39-45d5-92c5-1b5f1577dad8
endstream
endobj
7 0 obj
<>stream
x+ |
endstream
endobj
8 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
9 0 obj
<>stream
x+ |
endstream
endobj
10 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
14 0 obj
<>stream
/GS1 gs
BT
/F6 1 Tf
8.9663 0 0 8.9663 82.2047 484.7243 Tm
0 0 0 rg
0 Tc
0 Tw
[(CTE)-470.8(to)-470.9(support)-466(the)-472.9(screening,)-468.8(detection,)-473.1(diagnosis,)-472.9(prog-)]TJ
0 -1.2267 TD
[(nosis,)-335.7(assessment)-343.5(of)-336.7(therapeutic)-341.4(interventions,)-343.8(and)-336.1(determi-)]TJ
0 -1.2203 TD
[(nation)-336.3(of)-330.4(return)-337.5(to)-331.8(duty)-330.9(status?)]TJ
-1.2519 -1.2203 TD
[(5.)-501.9(Wh)24.3(at)-309(ar)21.2(e)-318.1(t)0(h)22.2(e)-318.1(st)21.1(ra)21.2(te)19.8(g)13.1(i)0(e)19.8(s)-316.8(t)15.4(h)0(a)17.5(t)-313.4(ca)15.1(n)-315.7(b)13.1(e)-318.1(u)13.1(se)16.3(d)-315.7(t)15.4(o)-322(p)13.1(re)21.2(v)13.1(e)0(n)17.5(t)15.4(,)-319.1(m)0(i)18.7(t)15.4(ig)22.3(at)19.8(e,)]TJ
1.2519 -1.2266 TD
[(o)13.1(r)-267.7(tr)19.6(ea)21.4(t)-269.1(n)13.1(eu)23.9(ro)23.7(de)17.5(g)13.1(e)0(n)17.5(e)0(r)21.2(a)0(t)26.2(i)0(o)22.2(n)-271.4(fo)23.7(ll)24.6(ow)16.6(i)15.4(n)0(g)-258.3(r)0(e)21.2(p)13.1(ea)21.4(te)19.8(d)-265.1(b)0(l)22.2(a)0(s)16.3(t)-262.8(ex)17.5(p)13.1(o)13.1(s)0(u)18.8(r)0(e)21.2(?)]TJ
-1.1381 -1.8336 TD
[(Following)-268.8(the)-276.9(meeting,)-275.2(a)-267.5(six-member)-276.7(expert)-274.1(panel)-272(convened)-275.2(to)]TJ
-1.1128 -1.2203 TD
[(highlight)-302.5(the)-302.1(major)-301(themes)-307.8(from)-297.6(the)-302.1(meeting,)-306.8(synthesize)-303.6(the)-302.1(rele-)]TJ
T*
[(vant)-390.2(ndings,)-389(identify)-392.6(knowledge)-387.1(gaps,)-390.3(and)-393(make)-392.1(recommenda-)]TJ
0 -1.2266 TD
[(tions.)-338.5(This)-338.2(process)-341.5(took)-337.2(into)-334.9(account)-343(the)-333.8(major)-338.9(discussion)-337.9(points)]TJ
0 -1.2203 TD
[(and)-323.4(key)-323.4(ideas)-330.1(that)-324.7(emerged)-326.1(from)-322.9(the)-321.1(focused)-327.7(working)-322.7(group)-322.6(ses-)]TJ
T*
[(sions,)-512.7(the)-510.8(literature)-516.8(review,)-514.3(the)-510.8(keynote,)-514.2(topical,)-509.6(and)-513.1(research)]TJ
0 -1.2266 TD
[(presentations,)-286.4(and)-279.2(the)-283.2(poster)-279.2(sessions.)]TJ
/F1 1 Tf
0 -3.5535 TD
[(SoS)-336.6(Expert)-331.4(Panel)-338.4(Findings)-336.9(and)-331.9(Recommendations)]TJ
/F6 1 Tf
1.1128 -1.8336 TD
[(The)-392.8(overarching)-396.8(nding)-398(is)-389.9(that)-400.5(existing)-391.1(scientic)-400.4(evidence)-395.5(is)]TJ
-1.1128 -1.2203 TD
[(insufcient)-342.7(to)-338.2(link)-341.2(blast-related)-341.9(TBI)-340.8(with)-344.5(CTE.)-340.9(The)-342.2(expert)-337.3(panel)]TJ
T*
[(acknowledged)-276.7(that)-274.1(this)-272.8(was,)-273.9(in)-268.6(part,)-275.6(because)-279.3(of)-267.2(a)-273.8(paucity)-275(of)-273.5(tissue)]TJ
0 -1.2266 TD
[(samples)-188.4(from)-183.8(those)-188.5(with)-186.4(well-annotated)-189.2(medical)-192.4(and)-184.3(blast)-186.2(exposure)]TJ
0 -1.2203 TD
[(histories.)-492.2(They)-487.1(concluded)-487.4(that)-489(without)-486.2(access)-496(to)-483.6(blast-exposed)]TJ
T*
[(tissue)-345(samples,)-343.1(a)-343.4(deeper)-342(exploration)-342.9(of)-343.1(potential)-345.3(associations)-345.8(be-)]TJ
0 -1.2267 TD
[(tween)-256.3(blast)-255.8(exposure)-257.6(and)-260.2(the)-251.6(development)-260.1(of)-254.5(CTE,)-258.7(including)-256.7(non-)]TJ
0 -1.2203 TD
[(blast)-224.2(risk)-220.8(factors,)-223.4(such)-223(as)-223.9(genetic)-220.5(susceptibility,)-229.8(age,)-221.3(and)-222.3(gender,)-222.4(as)]TJ
T*
[(well)-416.5(as)-413.6(co-morbidities)-416(such)-419(as)-413.6(drug,)-414.6(alcohol)-414.1(abuse,)-417.5(and)-411.9(cardio-)]TJ
0 -1.2266 TD
[(vascular)-283(disease,)-285(is)-282.4(not)-274.4(possible.)]TJ
1.1128 -1.2203 TD
[(The)-203.1(expert)-210.9(panel)-208.7(addressed)-203.8(this)-209.6(gap)-203.3(by)-207.7(calling)-203.2(for)-206.1(the)-207.3(creation)-210(of)]TJ
-1.1128 -1.2203 TD
[(a)-406.6(coordinated)-404.5(brain)-404.9(bank)-405.1(within)-410.8(the)-403.3(DoD)-403.5(to)-407.7(accept)-409.1(brain)-404.9(tissue)]TJ
T*
[(donations)-380.3(from)-386.2(deceased)-382.4(service)-384.7(members)-385.3(and)-380.3(ensure)-378.7(that)-381.6(these)]TJ
0 -1.2266 TD
[(tissue)-351.3(samples)-359.1(would)-346.3(be)-355.5(accessible)-352.7(to)-350.8(the)-352.7(broader)-354.4(research)-353.6(com-)]TJ
0 -1.2203 TD
[(munity.)-359.3(This)-363.5(brain)-360.7(bank)-360.9(would)-359(stand)-365.6(to)-357.1(complement)-365.2(and)-361.4(benet)]TJ
T*
[(from)-183.8(efforts)-182.7(already)-187.5(under)-179.6(way,)-184.2(such)-178.7(as)-186(the)-182(Brain)-182(Tissue)-189.1(Repository)]TJ
0 -1.2266 TD
[(that)-558.6(was)-555.5(established)-560.1(at)-555.6(the)-555.1(Center)-557(for)-553.8(Neuroscience)-561.1(and)-557.4(Re-)]TJ
0 -1.2203 TD
[(generative)-306.3(Medicine.)-305.9(To)-302.3(maximize)-303(participation,)-304.7(the)-302.2(expert)-299.4(panel)]TJ
T*
[(recommended)-412.3(that)-406.8(an)-406.1(education)-402.9(program)-406.1(be)-406.1(developed)-411.5(to)-407.7(teach)]TJ
0 -1.2267 TD
[(researchers)-408.9(strategies)-405.1(to)-401.4(address)-404.7(social)-403.2(and)-399.3(logistical)-406.9(barriers)-406(of)]TJ
0 -1.2203 TD
[(brain)-272.2(donation)-265.8(within)-271.7(the)-270.5(connes)-273.1(of)-267.2(regulatory,)-269(legal,)-272.6(and)-272.8(ethical)]TJ
T*
[(frameworks)-350.9(that)-343.6(govern)-349.9(tissue)-345(donation.)-344.6(A)-350.6(robust)-346.3(brain)-341.7(donation)]TJ
0 -1.2266 TD
[(repository)-498.8(that)-501.7(can)-502.9(be)-500.9(shared)-498.9(between)-504.3(DoD)-498.3(and)-500.5(academic)-502.6(re-)]TJ
0 -1.2203 TD
[(searchers)-284.7(is)-282.4(essential)-282.9(to)-281.3(determine)-282.6(whether)-283.2(there)-287.2(are)-277.9(distinct)-281.3(path-)]TJ
27.9978 47.5609 TD
[(ological)-265.9(features)-266.7(of)-260.9(CTE)-262.1(and)-260.2(whether)-264.3(these)-260.5(features)-266.7(are)-258.9(a)-267.5(result)-257.9(of)]TJ
0 -1.2267 TD
[(blast-related)-285(TBI.)]TJ
1.1128 -1.2203 TD
[(The)-228.4(expert)-223.5(panel)-227.7(also)-227(acknowledged)-226.1(that)-223.5(a)-229.6(major)-225.1(impediment)-221.4(to)]TJ
-1.1128 -1.2203 TD
[(denitive)-453.7(studies)-452(of)-444.2(CTE)-451.8(is)-446.8(a)-450.9(lack)-449.5(of)-450.6(validated)-451.2(diagnostic)-449.5(and)]TJ
0 -1.2266 TD
[(screening)-377.4(tools,)-363.8(including)-370.5(uid)-367.4(biomarker)-373.6(and)-367.7(neuroimaging)-367.2(ap-)]TJ
0 -1.2203 TD
[(proaches)-329.6(based)-319.7(on)-321.5(standardized)-325.5(clinical)-322.9(criteria.)-327(The)-323.2(only)-318.2(way)-320.4(to)]TJ
T*
[(identify)-392.5(CTE)-388.6(is)-389.9(through)-388.9(post-mortem)-391.6(autopsy)-389.9(of)-387.3(affected)-394.4(brains)]TJ
0 -1.2266 TD
[(using)-458(neuropathological)-456.3(criteria)-463.2(that)-451.1(are)-461.2(only)-451(just)-456.2(beginning)-455(to)]TJ
0 -1.2203 TD
[(achieve)-269.5(consensus.)]TJ
6.7246 0 0 5.9768 381.5432 400.9889 Tm
(17,18)Tj
8.9663 0 0 8.9663 399.0613 397.0204 Tm
[(Therefore,)-266.3(to)-262.3(facilitate)-267.8(the)-257.9(development)-266.4(of)]TJ
-9.5919 -1.2203 TD
[(ante-mortem)-262.5(diagnosis)-255(and)-253.9(screening)-263.6(approaches,)-258.1(the)-251.6(expert)-261.4(panel)]TJ
0 -1.2266 TD
[(recommended)-273.2(the)-270.5(establishment)-275.8(of)-267.2(an)-267(independent)-275.5(panel)-272(to)-268.6(assess)]TJ
0 -1.2203 TD
[(current)-687.2(biomarkers)-690.5(and)-683.8(provide)-688.5(recommendations)-685.2(for)-686.6(future)]TJ
T*
[(development)-494(of)-494.8(technologies,)-491.8(protocols,)-493.3(and)-487.8(analytics)-496.7(of)-488.5(next-)]TJ
T*
[(generation)-316.5(biomarkers.)-314(Noninvasive)-309.2(biomarkers)-311.1(would)-314.7(enable)-311.8(di-)]TJ
0 -1.2266 TD
[(agnosis)-271(not)-261.8(only)-261.3(in)-262.3(living)-268.4(subjects)-264.3(but)-261.8(could)-263.2(also)-264.9(be)-267(used)-260.9(to)-268.6(detect)]TJ
0 -1.2203 TD
[(potential)-674.1(neuroanatomical)-667.9(characteristics)-669.5(specic)-671.5(to)-667(CTE.)-663.4(A)]TJ
T*
[(longer-term)-284.4(component)-286.2(of)-279.8(the)-283.2(strategy)-278.3(called)-284.2(for)-282(the)-283.2(development)]TJ
0 -1.2266 TD
[(of)-507.5(high)-501.6(spatial)-507.9(resolution)-506.6(molecular)-503.9(imaging)-503.8(technologies)-507.8(that)]TJ
0 -1.2203 TD
[(would)-194.6(enable)-191.7(imaging)-193.9(of)-191.3(discreet)-198.5(brain)-190(locations)-197.1(and)-190.6(their)-194(function.)]TJ
1.1128 -1.2203 TD
[(A)-350.6(complementary)-349.8(and)-348.7(important)-351.3(component)-349.4(recommended)-355.4(by)]TJ
-1.1128 -1.2266 TD
[(the)-441.3(expert)-438.5(panel)-442.7(was)-441.7(for)-433.7(increasing)-444.2(research)-442.1(efforts)-442(toward)-439.4(the)]TJ
0 -1.2203 TD
[(development)-228.4(and)-222.3(validation)-224.7(of)-222.9(animal)-222.1(models)-223.2(clinically)-224.8(relevant)-222.6(to)]TJ
T*
[(blast-related)-190.2(TBI)-189(and)-184.3(chronic)-185.1(neurodegeneration.)-190.7(They)-190(emphasized)]TJ
0 -1.2266 TD
[(that)-299.4(animal)-304.3(models)-299.1(would)-295.7(likely)-302.4(accelerate)-300.9(the)-302.2(discovery)-299.1(of)-298.8(diag-)]TJ
0 -1.2203 TD
[(nostics)-350.9(and)-348.7(treatments)-356.9(and)-348.7(may)-345.9(represent)-354.7(the)-346.4(key)-348.7(to)-350.8(unlocking)-347.5(a)]TJ
T*
[(greater)-455.7(understanding)-459.2(of)-450.6(the)-453.9(pathophysiological)-456(mechanisms)-452.1(of)]TJ
T*
[(CTE.)-511.6(The)-512.9(expert)-508(panel)-512.2(stressed)-510.6(the)-510.8(importance)-509.7(of)-507.5(developing)]TJ
0 -1.2266 TD
[(clinically)-503(relevant)-494.5(models)-495.1(with)-496.3(standardized)-502.5(protocols)-496.7(that)-495.4(are)]TJ
0 -1.2203 TD
[(shared)-283.9(across)-285.1(the)-276.9(research)-284(community.)]TJ
1.1128 -1.2203 TD
[(In)-222.9(light)-218.3(of)-222.9(the)-220(research)-227.1(challenges)-222.7(faced)-222.4(and)-222.3(what)-222.8(little)-221.9(is)-219.2(known)]TJ
-1.1128 -1.2266 TD
[(about)-421.3(CTE,)-416.8(the)-416(expert)-419.5(panel)-417.4(recommended)-418.6(that)-419.5(an)-412.4(independent)]TJ
0 -1.2203 TD
[(panel)-512.2(be)-501(convened)-509.2(to)-502.6(determine)-510.2(whether)-510.9(ongoing)-500.1(longitudinal)]TJ
T*
[(studies)-395.1(could)-396(be)-393.5(leveraged)-397.6(to)-395.1(explore)-393.7(whether)-397(there)-394.7(is)-389.9(a)-393.9(spatio-)]TJ
0 -1.2266 TD
[(temporal)-381.8(development)-380.2(of)-374.7(CTE)-375.9(and)-374(candidate)-380.1(risk)-378.9(factors.)-375.2(These)]TJ
0 -1.2203 TD
[(studies)-287.6(could)-288.5(include)-281.3(the)-289.5(Defense)-282.8(and)-285.5(Veterans)-292.7(Brain)-283.2(Injury)-284.5(Cen-)]TJ
T*
[(ters)-219(15-year)-209(longitudinal)-212.7(study)-211.4(on)-214(TBI,)-210.9(the)-213.6(Traumatic)-212.9(Brain)-213.6(Injury)]TJ
T*
[(Model)-365.1(Systems)-361.6(study,)-359.8(the)-359.1(Chronic)-364.4(Effects)-359.4(of)-362(Neurotrauma)-365.7(Con-)]TJ
0 -1.2266 TD
[(sortium)-511.5(study,)-511.5(or)-507.5(the)-510.8(National)-515.8(Collegiate)-510(Athletic)-513.5(Association)]TJ
0 -1.2203 TD
[(Concussion)-628.3(Assessment,)-625.5(Research)-627.6(and)-620.6(Education)-621.6(Consortium)]TJ
T*
[(study.)-340.8(The)-335.9(panel)-341.5(would)-340(identify)-335.6(ways)-340.1(to)-338.2(strengthen)-340.6(these)-336.4(studies)]TJ
ET
62.022 720.113 490.167 .22681 re
f
62.022 528.945 490.167 .28345 re
f
62.022 698.343 490.167 .22675 re
f
62.022 617.272 490.167 .28351 re
f
BT
/F5 1 Tf
8.9663 0 0 8.9663 178.9795 725.7825 Tm
(Table)Tj
/F6 1 Tf
3.0034 0 TD
(1.)Tj
/F5 1 Tf
1.2456 0 TD
[(Literature)-332.5(Review)-336.7(Research)-335.5(Questions)-332.3(and)-337(Findings)]TJ
/F8 1 Tf
-17.2932 -2.3332 TD
[(Research)-334.3(questions)-31717.8(Findings)]TJ
/F4 1 Tf
0 -2.0929 TD
[(What)-333.9(is)-333(the)-337.3(current)-334.8(evidence)-335.7(describing)-336.1(the)-337.3(pathophysiolog-)]TJ
1.0875 -1.1128 TD
[(ical)-337.3(basis)-331.3(of)-336.7(CTE?)]TJ
/F9 1 Tf
26.9103 1.1128 TD
()Tj
/F6 1 Tf
1.0053 0 TD
[(An)-331.1(initial)-335.3(consensus)-332.8(has)-337.3(recently)-336.5(identied)-333.6(a)-337(specic)-336.4(neuro-)]TJ
.0885 -1.1128 TD
[(pathology)-334.9(thought)-333.4(to)-331.8(be)-330.2(required)-339(for)-332.5(a)-337(diagnosis)-330.9(of)-336.7(CTE.)]TJ
/F9 1 Tf
-29.0917 -1.1128 TD
()Tj
/F6 1 Tf
.999 0 TD
[(What)-303.6(biological)-300.6(processes)-306.2(following)-298.1(head)-300.1(injury)-304.9(are)-296.8(associated)]TJ
.0885 -1.1128 TD
[(with)-338.2(the)-333.8(development)-335.9(of)-330.4(CTE?)]TJ
/F9 1 Tf
26.9103 1.1128 TD
()Tj
/F6 1 Tf
1.0053 0 TD
[(Ongoing)-332.7(biomarker)-335.7(development,)-332.5(including)-338.9(neuroimaging)-335.6(and)]TJ
.0885 -1.1128 TD
[(biospecimen-based)-336.5(modalities,)-333.5(may)-339.6(enable)-330.8(identication)-335.7(and)]TJ
0 -1.1065 TD
[(study)-331.6(of)-336.7(CTE)-331.7(neuropathology)-337.4(in)-331.8(living)-331.6(persons.)]TJ
/F9 1 Tf
-29.0917 0 TD
()Tj
/F6 1 Tf
.999 0 TD
[(What)-335.2(advances)-335.7(in)-338.2(neuroimaging)-335.6(or)-330.4(biomarkers)-336.4(of)-330.4(CTE)-338(may)]TJ
.0885 -1.1128 TD
[(lead)-335.7(to)-331.8(the)-340.1(development)-335.9(of)-330.4(diagnostic)-335.7(tools)-335.6(or)-330.4(therapeutic)]TJ
T*
(strategies?)Tj
/F9 1 Tf
26.9103 1.1128 TD
()Tj
/F6 1 Tf
1.0053 0 TD
[(Treatment)-333(of)-336.7(CTE)-331.7(has)-337.3(not)-331.4(been)-338(established;)-336(therefore,)-333.7(current)]TJ
.0885 -1.1128 TD
[(mitigation)-331(strategies)-341.9(focus)-332.6(on)-334.1(prevention.)]TJ
/F4 1 Tf
-29.0917 -2.3711 TD
[(What)-333.9(associations)-338.1(are)-332.2(known)-331.7(between)-335.7(the)-337.3(mechanism\(s\))-334.5(of)]TJ
1.0875 -1.1128 TD
[(head)-339.1(injury)-332.1(\(e.g.,)-334.8(single)-336.1(or)-330.2(multiple)-334.9(exposures,)-340.4(impact)-329.3(or)]TJ
0 -1.1065 TD
[(nonimpact)-337.6(injury\))-334.2(and)-330.8(the)-337.3(development)-335.2(of)-330.4(CTE?)]TJ
/F9 1 Tf
-1.0875 -1.1128 TD
()Tj
/F6 1 Tf
.999 0 TD
[(Does)-333.7(the)-333.8(frequency)-336.9(of)-336.7(exposure)-333.5(to)-331.8(head)-338(injury)-330.2(correlate)-341(with)]TJ
.0885 -1.1128 TD
[(the)-333.8(development)-335.9(of)-336.7(CTE?)]TJ
/F9 1 Tf
26.9103 1.1128 TD
()Tj
/F6 1 Tf
1.0053 0 TD
[(Largely)-330.3(because)-342.6(of)-330.4(limitations)-335.7(in)-331.8(clinical)-335.6(data)-335.7(collection,)]TJ
.0885 -1.1128 TD
[(associations)-333.2(between)-340(CTE)-331.7(development)-335.9(and)-336.1(1\))-330.4(frequency)-336.9(of)]TJ
T*
[(head)-331.7(injury)-336.5(or)-330.4(2\))-336.7(type)-333.3(of)-330.4(head)-338(injury)-330.2(cannot)-334.7(be)-336.6(determined.)]TJ
/F9 1 Tf
-29.0917 0 TD
()Tj
/F6 1 Tf
.999 0 TD
[(Are)-335.6(there)-337.8(any)-329.7(known)-336(distinctions)-335.2(between)-340(how)-330.6(impact)-335.9(injury,)]TJ
.0885 -1.1065 TD
[(nonimpact)-334.5(injury,)-333.1(and)-329.7(blast-induced)-332.9(injury)-330.2(are)-328.4(associated)-337.7(with)]TJ
0 -1.1128 TD
[(the)-333.8(development)-335.9(of)-336.7(CTE?)]TJ
7.9702 0 0 7.9702 70.0157 517.1526 Tm
[(CTE,)-324.3(chronic)-328.1(traumatic)-327.6(encephalopat)11.9(hy.)]TJ
/F1 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(S-2)Tj
46.3153 0 TD
[(LEGGIERI)-333.6(ET)-338.7(AL.)]TJ
ET
endstream
endobj
25 0 obj
<>stream
IHIJDA+AdvP4C4E74 wR` C15AdvP4C4E74 s 3!%0; 5|#p3Lp|~zx~M~c~kqqt
endstream
endobj
29 0 obj
<>stream
/GS1 gs
BT
/F6 1 Tf
8.9663 0 0 8.9663 59.7543 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(and)-411.9(maximize)-416.8(their)-409(usefulness)-414.8(for)-408.4(shedding)-414.7(light)-408(on)-410(CTE.)-410.5(This)]TJ
0 -1.2203 TD
[(could)-434(include,)-429.7(for)-433.7(example,)-431.6(identifying)-433(gaps)-425.3(in)-433(the)-428.6(studies)-433.1(that)]TJ
0 -1.2266 TD
[(could)-452.9(be)-450.4(lled)-449.2(by)-448(a)-450.9(neuropathological)-456.3(component)-450.6(or)-450.6(using)-451.7(the)]TJ
0 -1.2203 TD
[(ongoing)-285.1(studies)-281.3(to)-274.9(explore)-286.3(nonblast)-279.6(CTE)-281.1(risk)-284.1(factors.)]TJ
1.1128 -1.2203 TD
[(The)-316.9(expert)-318.4(panel)-316.2(noted)-313.8(that)-318.3(additional)-313.2(large)-318.8(prospective)-317.2(longi-)]TJ
-1.1128 -1.2266 TD
[(tudinal)-466.3(clinical)-462(studies)-458.3(of)-463.2(service)-460.6(members)-461.2(with,)-461.2(or)-463.2(at)-460.7(risk)-461.1(of,)]TJ
0 -1.2203 TD
[(combat-related)-449.7(blast)-451.8(injury)-444(may)-447.1(still)-444.8(be)-444(needed,)-449.8(and)-443.6(should)-444.9(be)]TJ
T*
[(initiated,)-428.1(to)-426.7(adequately)-430.1(characterize)-429(the)-428.6(association)-427.3(between)-428.5(re-)]TJ
0 -1.2266 TD
[(peated)-457.3(blast)-451.8(exposure)-453.6(and)-456.2(CTE.)-454.7(They)-449.2(recommended)-456.6(that)-457.4(these)]TJ
0 -1.2203 TD
[(studies)-458.3(collect)-458.5(detailed)-464.3(medical)-458(histories)-457.7(on)-454.3(at-risk)-456(populations)]TJ
T*
[(such)-292.5(as)-287.2(breachers)-296.2(or)-286.2(gunners)-293.6(who)-286.4(have)-293.7(more)-291.1(predictable)-290.8(and)-291.8(reli-)]TJ
T*
[(able)-386.3(blast)-382.3(exposures)-384.8(histories)-381.8(\(e.g.,)-385.4(frequency,)-384(magnitude\))-380.9(when)]TJ
0 -1.2266 TD
[(compared)-521.6(with)-521.5(other)-518.8(study)-521.2(populations.)-519.1(To)-517.3(complement)-523.3(these)]TJ
0 -1.2203 TD
[(efforts,)-236.2(the)-238.9(expert)-236.2(panel)-234(called)-233.7(for)-237.7(the)-232.6(continuous)-234.4(monitoring)-234.6(of)-235.6(at-)]TJ
T*
[(risk)-296.7(populations)-294.8(to)-287.6(help)-295.3(establish)-293.1(a)-292.8(dose-response)-300.5(relationship)-290.7(be-)]TJ
0 -1.2266 TD
[(tween)-269(blast)-262.1(intensity,)-264.8(frequency,)-263.9(and)-260.2(resulting)-266.8(injury)-260.6(severity)-265.7(with)]TJ
0 -1.2203 TD
[(improved)-476.6(sensor)-478.7(technology.)-478.8(Outcomes)-474.5(of)-475.8(these)-481.8(studies)-477.3(would)]TJ
T*
[(inform)-256.4(efforts)-252.3(to)-256(establish)-255.1(standardized)-255.9(clinical)-253.4(diagnostic)-253.5(criteria,)]TJ
0 -1.2266 TD
[(the)-283.2(lack)-278.8(of)-286.2(which)-279.2(is)-282.4(a)-280.1(major)-282(gap.)]TJ
1.1128 -1.2203 TD
[(Given)-266.5(the)-264.2(current)-263.6(state)-264.5(of)-260.9(the)-264.2(science)-264.4(regarding)-268.9(the)-257.9(relationship)]TJ
-1.1128 -1.2203 TD
[(between)-333.6(blast-related)-329.3(TBI)-328.1(and)-323.4(CTE,)-328.3(it)-323.2(is)-326.7(important)-332.4(to)-325.5(implement)]TJ
T*
[(prevention)-282.5(and)-279.2(mitigation)-280.4(strategies)-278.7(of)-279.8(blast-related)-285(TBI.)-274.2(Some)-280.8(of)]TJ
0 -1.2266 TD
[(these)-191(strategies)-183.8(include)-186.5(modifying)-186.8(training)-183.9(protocols)-186.9(to)-186.4(reduce)-184(blast)]TJ
0 -1.2203 TD
[(exposure)-434.7(\(e.g.,)-429.6(breacher)-434.6(training,)-427.1(weapon)-435.2(systems)-427.4(training\))-432.6(and)]TJ
T*
[(educating)-282.8(military)-286.3(instructors)-282.3(about)-282.2(long-term)-280.4(exposure)-282.9(risks.)-281.4(Im-)]TJ
0 -1.2266 TD
[(proving)-256.1(personal)-249(protective)-257.3(equipment)-252.3(and)-247.5(limiting)-253.7(blast)-249.5(exposure)]TJ
0 -1.2203 TD
[(are)-271.5(perhaps)-277.1(the)-270.5(most)-272.4(promising)-270.2(areas)-267.8(for)-275.6(preventing)-269.8(blast-induced)]TJ
T*
[(TBI.)-470.2(The)-475(expert)-470.1(panel)-468(also)-473.6(emphasized)-475.1(the)-466.5(importance)-471.8(of)-469.5(im-)]TJ
0 -1.2266 TD
[(plementing)-331.7(current)-326.8(return-to-duty)-327.9(guidelines)-329.4(after)-327.8(blast)-325.4(exposure,)]TJ
0 -1.2203 TD
[(but)-287.1(also)-290.2(questioned)-293.7(their)-288.8(basis)-284.6(in)-287.6(evidence)-294.3(and)-285.5(recommended)-292.2(that)]TJ
T*
[(the)-207.3(extent)-212.3(to)-205.4(which)-209.6(the)-207.3(guidelines)-209.2(minimize)-209.7(the)-207.3(risk)-208.2(of)-204(blast-related)]TJ
0 -1.2266 TD
[(TBI)-283.9(be)-279.6(evaluated.)]TJ
1.1128 -1.2203 TD
[(The)-304.3(articles)-310.1(presented)-301.5(in)-306.5(this)-304.5(Supplement)-301(represent)-310.5(a)-299.1(sampling)]TJ
-1.1128 -1.2203 TD
[(of)-317.8(the)-314.8(work)-313.8(presented)-314.2(at)-315.3(the)-314.8(meeting)-316.5(and)-317.1(exemplify)-318.1(the)-314.8(multidis-)]TJ
T*
[(ciplinary)-413.4(approaches)-413.2(that)-413.2(are)-410.6(under)-413.6(way)-408.9(to)-414(elucidate)-409.4(the)-416(patho-)]TJ
0 -1.2266 TD
[(physiological)-350.9(basis)-347.8(of)-349.4(CTE,)-347.2(identify)-348.3(whether)-346.5(there)-350.5(is)-345.7(a)-343.4(link)-347.5(with)]TJ
0 -1.2203 TD
[(repeated)-353.8(blast-related)-348.3(TBI,)-350(and)-342.4(determine)-352.1(the)-346.4(long-term)-349.9(implica-)]TJ
T*
[(tions)-335.6(of)-324.1(blast-related)-335.6(TBI.)-331.1(This)-331.9(knowledge)-330.2(base)-332.9(is)-333(crucial)-330.6(for)-326.2(the)]TJ
0 -1.2266 TD
[(development)-494(of)-494.8(effective)-499.1(prevention,)-494.1(mitigation,)-492(and)-494.1(treatment)]TJ
0 -1.2203 TD
[(strategies)-405.1(for)-402.1(service)-403.7(members)-404.3(and)-405.6(veterans)-403.2(who)-400.2(have)-401.2(been)-401.2(ex-)]TJ
T*
[(posed)-285.7(to)-274.9(blast)-287.4(or)-279.8(have)-281.1(endured)-282.2(blast-related)-285(TBI.)]TJ
/F1 1 Tf
0 -2.447 TD
(References)Tj
/F6 1 Tf
7.9702 0 0 7.9702 63.7228 250.5826 Tm
-.0231 Tc
[(1)-23.1(.)-525(Insti)-5.3(t)1.8(ute)-301.6(o).3(f)-294.7(M)1.2(edicine.)]TJ
/F8 1 Tf
9.8446 0 TD
-.0237 Tc
[(Gul)-5.9(f)-297.5(War)-300.2(a)6.8(nd)-306.1(Health:)-302.4(V)-.1(olume)-295.1(7)-.3(:)-302.4(L)1.9(ong-Term)-301.5(Con-)]TJ
-8.5927 -1.131 TD
[(sequences)-314.3(of)-318.8(Traumatic)-316.4(Brai)-5.8(n)-313.2(I)-3.6(njury.)]TJ
/F6 1 Tf
14.8167 0 TD
[(Available)-323.5(a)3.7(t:)-318.8(The)-323.5(N)4.4(ational)-318.8(A)4.4(cade-)]TJ
-14.8167 -1.1239 TD
-.0231 Tc
[(mies)-278.3(Pres)6.2(s.)-285.2(h)7.4(t)-5.3(tps://)-5.3(d)7.4(o).3(i)-5.3(.)-.7(o)7.4(r)-3.1(g/10.17226/12436)7.4(.)-285.2(A)4.9(ccessed)-277.1(A)4.9(ugus)-278.3(31,)-278.1(2017.)]TJ
-1.2519 -1.1239 TD
0 Tc
[(2.)-501.9(DCAS)-546.9(-)-549(Home.)-547.6(Def.)-549.6(Casualty)-547.5(Anal.)-549.7(Syst.)-542.9([cited)-549.2(2015)-546.5(Feb)-549.6(18)-550.7(])]TJ
1.2519 -1.1239 TD
[(Availabl)12.2(e)-669.8(at:)-669.7(www.dmdc.o)11.6(sd.mil/dcas/)10.5(pages/main.)10.5(xhtml.)-664.8(Accessed)]TJ
T*
[(Augus)-327.6(31,)-329.1(2017.)]TJ
-1.2519 -1.1239 TD
-.0151 Tc
[(3)-15.1(.)-517(DoD)-428.1(W)-15.1(o)9.3(r)-15.1(l)8.5(d)1.2(wi)-15.1(d)11.9(e)-428.8(Nu)-15.1(m)14(b)-15.1(e)7.2(r)-15.1(s)-413.9(f)-15.1(o)7(r)-429(TB)-15.1(I)9.4(.)-433.7(DVBI)-15.1(C)-417.4(Av)-15.1(a)7.2(i)-15.1(l)13.4(a)-15.1(b)7.2(l)2.7(e)-435.9(a)-15.1(t)15.8(:)-431.2(d)-15.1(v)10.4(bi)-15.1(c)8.7(.).2(d)-15.1(c)7.2(oe)]TJ
1.2519 -1.131 TD
0 Tc
[(.)15.3(m)0(i)30.6(l)0(/)21.4(d)16.3(o)16.3(d)0(-)22.1(w)13.8(o)16.3(r)0(l)23.6(d)16.3(w)13.8(i)0(d)27(e)0(-)26(n)16.3(um)29.1(be)22.3(rs)28(-t)23.6(b)16.3(i)0(.)-308.4(A)13.8(cc)26.2(es)28.2(se)21.1(d)-318(A)13.8(u)16.3(g)16.3(u)0(s)24.3(t)-323.6(3)16.3(1)16.3(,)-319(20)25.5(1)16.3(7)0(.)]TJ
-1.2519 -1.1239 TD
[(4.)-501.9(Belanger,)-226.2(H.G.,)-232.5(Scott,)-228.4(S.G.,)-227.8(Scholten,)-225.4(J.,)-231.8(Curtiss,)-226.6(G.,)-233.1(and)-231.7(Vanderploeg,)]TJ
1.2519 -1.1239 TD
[(R.D.)-506(\(2005\).)-512.5(Utility)-506.8(of)-511.4(mechanism-o)10.2(f-injury-based)-501.2(assessment)-507.8(and)]TJ
T*
[(treatment:)-245.8(Blast)-244.7(Injury)-248.9(Program)-245.7(case)-251.5(illustration)12(.)-255(J)0(.)-254.1(Rehabil.)-241.5(Res.)-250.8(Dev.)]TJ
T*
[(42,)-329.1(403412)14.5(.)]TJ
30.2522 72.0489 TD
[(5.)-494.8(Belanger,)-425.4(H.G.)-432.7(and)-430.9(Vanderploeg,)-424(R.D.)-434.9(\(2005\).)-427.2(The)-430.7(neuropsycho)11.8(lo-)]TJ
1.2448 -1.1239 TD
[(gical)-547.8(impact)-542.2(of)-547(sports-re)11.5(lated)-547.8(concussio)11.4(n:)-549.2(a)-548.8(meta-analy)11.2(sis.)-548.4(J.)-545.8(Int.)]TJ
T*
[(Neuropsychol)12.9(.)-333.3(Soc.)-328(JINS)-330.9(11,)-329.1(345357.)]TJ
-1.2448 -1.131 TD
[(6.)-494.8(Schretlen,)-251.2(D.J.)-253.5(and)-260.2(Shapiro,)-250.5(A.M.)-251.5(\(2003\).)-249.4(A)-263.6(quantitative)-247.4(review)-254.4(of)-255.3(the)]TJ
1.2448 -1.1239 TD
[(effects)-407(of)-411.8(traumatic)-405.9(brain)-407.3(injury)-407.6(on)-408.4(cognitive)-402.9(functioning.)-405(Int.)-407.2(Rev.)]TJ
T*
[(Psychiatry)-326.4(15,)-329.1(341349)14.5(.)]TJ
-1.2448 -1.1239 TD
[(7.)-494.8(Re)24.7(i)17.8(d)0(,)-224.5(M)0(.)25.3(W)15.2(.)-240.8(a)0(n)29.4(d)-239.8(V)13.8(e)0(l)23.8(e)0(z)26.2(,)-233.7(C.)26.9(S.)-222.3(\(2)22.1(0)16.3(1)16.3(5)0(\))22.1(.)-233.7(D)13.8(i)0(s)25.8(c)0(r)26(i)0(m)23.5(i)17.8(na)22.3(t)17.8(i)0(n)27(g)-239.8(mi)30.6(li)21.4(t)17.8(a)0(r)26(y)-239.8(an)22.3(d)-232.7(c)0(i)23.8(v)16.3(il)21.4(i)17.8(a)0(n)]TJ
1.2448 -1.1239 TD
[(tr)23.6(au)29.4(ma)25.9(ti)28.5(c)-321.2(b)16.3(ra)26(in)-307.3(in)27(ju)27(ri)23.6(es)28.2(.)-319(M)0(o)26.4(l)0(.)-308.4(C)0(e)24.7(l)17.8(l.)-308.4(N)13.8(e)0(u)22.3(r)0(o)29.2(s)15.1(ci)23.8(.)-319(6)16.3(6,)-309.9(P)18.5(a)0(r)26(t)-323.6(B,)-307.5(1)16.3(2)16.3(3)0()25.5(1)16.3(28)25.5(.)]TJ
-1.2448 -1.1239 TD
[(8.)-494.8(McKee,)-334.1(A.C.,)-327.2(Cantu,)-336.4(R.C.,)-329.4(Nowinski,)-327(C.J.,)-333(Hedley-W)11.8(hyte,)-333.8(E.T.,)-333.8(Ga-)]TJ
1.2448 -1.1239 TD
[(vett,)-318(B.E.,)-310.2(Budson,)-312.5(A.E.,)-315.1(Santini,)-315.2(V.E.,)-315.1(Lee,)-311.9(H.S.,)-313.1(Kubilus,)-312.3(C.A.,)-312.9(and)]TJ
0 -1.131 TD
[(Stern,)-524.9(R.A.)-520.2(\(2009\).)-519.7(Chronic)-521.6(traumatic)-519.7(encephalopat)11.9(hy)-522.2(in)-527.8(athletes:)]TJ
0 -1.1239 TD
[(progressive)-517.6(tauopath)13.2(y)-524.3(after)-520.6(repetitive)-519.7(head)-524.5(injury.)-513.2(J.)-524.4(Neuropathol)13.5(.)]TJ
T*
[(Exp.)-326.9(Neurol.)-328.4(68,)-329.1(709735.)]TJ
-1.2448 -1.1239 TD
[(9.)-494.8(McKee,)-312.8(A.C.,)-312.9(Gavett,)-319.6(B.E.,)-310.2(Stern,)-311.6(R.A.,)-320(Nowinski)13.4(,)-319.1(C.J.,)-318.7(Cantu,)-308(R.C.,)]TJ
1.2448 -1.1239 TD
[(Kowall,)-269.1(N.W.,)-266.7(Perl,)-271(D.P.,)-263.3(Hedley-Whyt)12.4(e,)-270.4(E.T.,)-269.8(Price,)-272.1(B.,)-270.9(Sullivan)13(,)-276.4(C.,)]TJ
T*
[(Morin,)-259.9(P.,)-263.9(Lee,)-262.1(H.-S.,)-264.6(Kubilu)13(s,)-268.4(C.A.,)-263.1(Daneshv)11.5(ar,)-264.6(D.H.,)-260.9(Wulff,)-265.3(M.,)-258.1(and)]TJ
0 -1.131 TD
[(Budson,)-241.4(A.E.)-237.9(\(2010\).)-235.1(TDP-43)-240(proteinopath)12.5(y)-246.9(and)-245.9(motor)-236.9(neuron)-236(disease)]TJ
0 -1.1239 TD
[(in)-264.6(chronic)-264.1(traumatic)-263.6(encephal)12.4(opathy.)-265.6(J.)-261.3(Neuropathol.)-255.7(Exp.)-262.8(Neurol.)-264.4(69,)]TJ
T*
(918929.)Tj
-1.7427 -1.1239 TD
[(10.)-492.7(Miller,)-378.9(H.)-383.5(\(1966\).)-377.4(Mental)-381.3(after-effects)-381.2(of)-383.4(head)-382.2(injury.)-378.1(Proc.)-379.2(R.)-385.7(Soc.)]TJ
1.7427 -1.1239 TD
[(Med.)-329.4(59,)-329.1(257261.)]TJ
-1.7427 -1.1239 TD
[(11.)-492.7(Omalu,)-387.5(B.,)-391.8(DeKosky)12.2(,)-390.2(S.T.,)-388.7(Minster,)-386.6(R.L.,)-388.5(Kamboh,)-387(M.I.,)-386.5(Hamilton)11.9(,)]TJ
1.7427 -1.1239 TD
[(R.L.,)-288.9(and)-281.5(Wecht,)-286.2(C.H.)-285.5(\(2005\).)-284.9(Chronic)-279.8(traumatic)-285(encephalopat)11.9(hy)-287.5(in)-293.1(a)]TJ
0 -1.131 TD
[(National)-329.2(Football)-321.3(League)-331.3(player.)-329.1(Neurosurg)12.1(ery)-334.7(57,)-329.1(128134)14.5(.)]TJ
-1.7427 -1.1239 TD
[(12.)-492.7(Hazrati,)-459.3(L.N.,)-464.5(Tartaglia,)-458(M.C.,)-466(Diamandi)14.3(s,)-467.5(P.,)-463.1(Davis,)-463.4(K.D.,)-460.1(Green,)]TJ
1.7427 -1.1239 TD
[(R.E.,)-310.2(Wennberg,)-306.3(R.,)-313.5(Wong,)-304.8(J.C.,)-311.6(Ezerins,)-313.8(L.,)-308.6(and)-310(Tator,)-313.6(C.H.)-306.9(\(2013\).)]TJ
T*
[(Absence)-624.7(of)-625.2(chronic)-619.7(traumatic)-619.3(encephalopathy)-617(in)-627.4(retired)-621.6(football)]TJ
T*
[(players)-329.3(with)-332.6(multiple)-325.5(concussio)11.4(ns)-338.5(and)-331.3(neurologi)15.1(cal)-333(symptomatolog)13(y.)]TJ
T*
[(Front.)-329.7(Hum.)-326(Neurosci.)-328.7(7,)-331.2(222.)]TJ
-1.7427 -1.131 TD
[(13.)-492.7(Karantzouli)11.9(s,)-346.6(S.)-336.1(and)-345.5(Randolph,)-330.2(C.)-343(\(2013\).)-334.7(Modern)-334.7(chronic)-335.2(traumatic)]TJ
1.7427 -1.1239 TD
[(encephalopat)11.9(hy)-671.6(in)-677.2(retired)-664.3(athletes:)-668.9(what)-671.6(is)-671.3(the)-671.2(evidence?)-671.6(Neu-)]TJ
T*
[(ropsychol.)-320.9(Rev.)-335(23,)-329.1(350360)14.5(.)]TJ
-1.7427 -1.1239 TD
[(14.)-492.7(McCrory,)-560.2(P.,)-562.7(Meeuwi)13.1(sse,)-567.4(W.H.,)-558.3(Kutcher,)-557.2(J.S.,)-560.8(Jordan,)-563.3(B.D.,)-554.8(and)]TJ
1.7427 -1.1239 TD
[(Gardner,)-469.6(A.)-476(\(2013\).)-469.9(What)-478.2(is)-472.1(the)-479.2(evidence)-471.3(for)-477.1(chronic)-470.3(concussio)11.4(n-)]TJ
T*
[(related)-593(changes)-593.8(in)-598.9(retired)-593.1(athletes:)-590.7(behavioural)12.9(,)-603.6(pathologi)12.9(cal)-596.2(and)]TJ
T*
[(clinical)-328.4(outcomes?)-328.4(Br.)-330.1(J.)-332.4(Sports)-322.7(Med.)-329.4(47,)-329.1(327330.)]TJ
-1.7427 -1.131 TD
[(15.)-492.7(Randolph,)-330.2(C.)-335.9(\(2014\).)-334.7(Is)-334.7(chronic)-335.2(traumatic)-334.8(encephalopat)11.9(hy)-337.3(a)-342.6(real)-334.3(dis-)]TJ
1.7427 -1.1239 TD
[(ease?)-330.8(Curr.)-329.4(Sports)-329.8(Med.)-329.4(Rep.)-327.9(13,)-329.1(3337.)]TJ
-1.7427 -1.1239 TD
[(16.)-492.7(Wortzel,)-276.9(H.S.,)-284.7(Brenner,)-272.6(L.A.,)-279.6(and)-281.5(Arciniegas,)-276.4(D.B.)-285.5(\(2013\).)-277.8(Traumatic)]TJ
1.7427 -1.1239 TD
[(brain)-336.1(injury)-336.5(and)-338.4(chronic)-335.2(traumatic)-334.8(encephalopathy:)-328.9(a)-342.6(forensic)-337.7(neuro-)]TJ
T*
[(psychiatric)-328.3(perspect)11(ive.)-335.9(Behav.)-326.9(Sci.)-326.5(Law)-333.6(31,)-329.1(721738)14.5(.)]TJ
-1.7427 -1.1239 TD
[(17.)-492.7(McKee,)-355.5(A.C.,)-355.6(Alvarez,)-347(V.,)-361.1(Bieniek,)-348.2(K.,)-354(Cairns,)-353.1(N.,)-361.1(Crary,)-351.8(J.,)-352.7(Dams-)]TJ
1.7427 -1.131 TD
[(OConnor,)-501.4(K.,)-503.4(Folkerth,)-495.9(R.,)-505.6(Keene,)-505.7(C.D.,)-505(Litvan,)-498.6(I.,)-511.4(Montine,)-495.9(T.,)]TJ
0 -1.1239 TD
[(Montenigro,)-400.6(P.,)-406.2(Perl,)-406.1(D.,)-410.9(Stein,)-406.2(T.,)-401.1(Stewart,)-411.2(W.,)-402.4(Tripodis,)-403.4(Y.,)-410.9(Von-)]TJ
T*
[(sattel,)-238.5(J.P.,)-233.6(Gordon,)-234.2(W.,)-238.8(and)-238.8(Dickson,)-231.7(D.)-241.2(\(2015\).)-235.1(Prelimina)12.1(ry)-241.1(results)-233.3(of)]TJ
T*
[(the)-415.1(NINDS/NIBIB)-408.5(Consensus)-412.5(Meeting)-414.8(to)-421.1(evaluate)-412.9(pathologi)12.9(cal)-425.5(cri-)]TJ
T*
[(teria)-330.7(for)-327.8(the)-336.9(diagnosis)-325.3(of)-326.4(CTE)-332.4(\(P2.178\).)-322.3(Neurology)-323.2(84,)-329.1(P2.178.)]TJ
-1.7427 -1.1239 TD
[(18.)-492.7(McKee,)-455.1(A.C.,)-455.2(Cairns,)-452.7(N.J.,)-458.8(Dickson,)-452.2(D.W.,)-451.6(Folkerth,)-453.2(R.D.,)-455.2(Keene,)]TJ
1.7427 -1.1239 TD
[(C.D.,)-362.7(Litvan,)-356.4(I.,)-369.1(Perl,)-356.3(D.P.,)-362.9(Stein,)-363.6(T.D.,)-357.8(Vonsattel,)-362.9(J.P.,)-361.6(Stewar)11(t,)-365.3(W.,)]TJ
0 -1.131 TD
[(Tripodis,)-268.2(Y.,)-282.9(Crary,)-273.6(J.F.,)-276.2(Bieniek,)-269.9(K.F.,)-277.5(Dams-OC)13.5(onnor,)-276.5(K.,)-275.8(Alvarez,)]TJ
0 -1.1239 TD
[(V.E.,)-364.9(Gordon,)-369.4(W.A.,)-366.2(and)-366.9(TBI/CTE)-366.1(group.)-361.8(\(2016\).)-363.2(The)-373.8(rst)-362.4(NINDS/)]TJ
T*
[(NIBIB)-321.3(consensus)-311.4(meeting)-319.6(to)-321.5(dene)-321(neurop)13(athological)-315.1(criteria)-322.5(for)-320.6(the)]TJ
T*
[(diagnosis)-524.5(of)-532.7(chronic)-520.1(traumatic)-526.8(encephalopat)11.9(hy.)-528.3(Acta)-532.6(Neuropathol)13.5(.)]TJ
T*
[(131,)-327(7586.)]TJ
8.9663 0 0 8.9663 448.7243 238.6204 Tm
[(Address)-336.1(correspondence)-334.1(to:)]TJ
/F8 1 Tf
3.3954 -1.2266 TD
[(Raj)-331.2(K.)-335.9(Gupta,)-330.3(PhD)]TJ
-14.7387 -1.2203 TD
[(Department)-338.3(of)-331.8(Defense)-334.8(Blast)-335.4(Injury)-336.1(Research)-334.3(Program)]TJ
14.5048 -1.2203 TD
[(Coordinating)-334.6(Ofce)]TJ
-17.5777 -1.2267 TD
[(United)-333.3(States)-337.5(Army)-333.6(Medical)-334(Research)-340.6(and)-333.7(Materiel)-332.4(Command)]TJ
19.1837 -1.2203 TD
[(504)-333.6(Scott)-336.8(Street)]TJ
-3.5724 -1.2203 TD
[(Fort)-338.2(Detrick,)-335.4(MD)-333.2(21702)]TJ
-3.3701 -2.3332 TD
(E-mail:)Tj
/F6 1 Tf
3.3891 0 TD
(raj.k.gupta.civ@mail.mil)Tj
/F1 1 Tf
-44.5955 66.6688 TD
[(BLAST-RELATED)-342.3(TRAUMA)-334.7(AND)-337.2(CTE)]TJ
53.1188 0 TD
(S-3)Tj
ET
endstream
endobj
33 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
34 0 obj
<>stream
htWyTS9;
sbVkZkjEAf IHH9L (('֩Z;v;{O]u8'|{ۿ_ob(/$$ֿjܨ4/Yxi~*?pf@\)}Rݴ*@)̒f-\t3{eJ,=O*Z/N͗KRdiϊDQ T.Mȹ;ҥl(E$H3D2eA(j(E6?_"OZW"N>x!oJ(P( Pނ"[0/^MYxy[!
1t}.+6L83qD6 []{%.!
&zx'M)S<jհSWLx( h\(Q|Cٺc
4RCf(.R81(OˉC݅yyɾfF`~|a}2ZGM B|_ ϠHpBE-3?3iP
d8xL{7;0żNOG͔0A>Im0hJS[
BL`L[BNvԶ[ۿ.AЂYs}|˦6$Bsd
?
@,=́n0ſۋV)akGqXA $J TϯD1sTLUpbQ @7>0hZAwwqW>@Oa8WRq~o6(@-7O"I/~[^bPS